0
Back To Top Jump Location
Sign In  | Cart
Left Shadow
Right Shadow
Articles |

Influence of left ventricular hypertrophy on detection of coronary artery disease using exercise echocardiography FREE

Thomas H. Marwick, MD, PhD, FACC; Julius Torelli, MD; Kishore Harjai, MD; Brian Haluska, RDMS; Fredric J. Pashkow, MD; William J. Stewart, MD, FACC; James D. Thomas, MD, FACC
[+] Author Information

Address for correspondence: Dr. Thomas H. Marwick, Department of Cardiology, F15, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195.

American College of Cardiology

J Am Coll Cardiol. 1995;26(5):1180-1186. doi:10.1016/0735-1097(96)81472-0
Published online

Objectives.  This study examined the influence of left ventricular hypertrophy on the accuracy of exercise electrocardiography and echocardiography for detection of coronary artery disease.

Background.  Electrocardiographic repolarization abnormalities caused by left ventricular hypertrophy compromise the diagnostic accuracy of exercise electrocardiography but not of exercise echocardiography. The relative merits of these investigations are less well defined in patients with hypertrophy but without electrocardiographic (ECG) changes.

Methods.  We prospectively evaluated 147 consecutive patients without prior myocardial infarction undergoing both exercise echocardiography and coronary arteriography. Coronary stenoses >50% diameter were present in 62 patients (42%). Positive test results were defined by a new or worsening wall motion abnormality or >0.1 mV of ST depression. Echocardiographic left ventricular hypertrophy (mass >131 g/m2 in men, >100 g/m2 in women) was identified in 68 patients. A subgroup with clinically suspected hypertrophy was defined according to the presence of ECG evidence of hypertrophy, hypertension or aortic stenosis.

Results.  The overall sensitivity of exercise echocardiography exceeded that of exercise electrocardiography (71% vs. 54%, p = 0.06). Echocardiographic hypertrophy had no significant effect on the sensitivity of either test. The specificity of exercise echocardiography exceeded that of exercise electrocardiography (91 vs. 74%, p = 0.01). In patients with hypertrophy, the specificity of exercise echocardiography exceeded that of exercise electrocardiography (95% vs. 69%, p < 0.01), whereas among patients without hypertrophy, the specificities (respectively, 87% and 78%) were more comparable. The accuracy of exercise echocardiography exceeded that of the exercise ECG in the overall group (82% vs. 65%, p = 0.002) and in patients with hypertrophy (85% vs. 60%, p = 0.004), but this difference was less prominent in patients without hypertrophy (80% vs. 69%, p = NS). In patients with clinically suspected hypertrophy, exercise echocardiography demonstrated a higher sensitivity, specificity and accuracy than exercise electrocardiography. The cost incurred in the identification of coronary disease was least with a strategy involving use of the exercise echocardiogram instead of routine exercise testing in patients with known or clinically suspected left ventricular hypertrophy.

Conclusions.  Exercise echocardiography is more accurate than exercise electrocardiography for the detection of coronary artery disease in patients with known or clinically suspected left ventricular hypertrophy.

References

Harris  CN, Aronow  WS, Parker  DP, Kaplan  MA; Treadmill stress test in left ventricular hypertrophy. Chest. 63 1973:353-358.
CrossRef | PubMed
Ellestad  MH, Savitz  S, Bergdall  D, Teske  J; The false positive stress test multivariate analysis of 215 subjects with hemodynamic, angiographic and clinical data. Am J Cardiol. 40 1977:681-685.
CrossRef | PubMed
Prisant  LM, Frank  MJ, Carr  AA, von Dohlen  TW, Abdulla  AM; How can we diagnose coronary heart disease in hypertensive patients?. Hypertension. 10 1987:467-472.
CrossRef | PubMed
Tomanek  RJ, Palmer  PJ, Peiffer  GL, Schreiber  KL, Eastham  CL, Marcus  ML; Morphometry of canine coronary arteries, arterioles and capilleries during hypertension and left ventricular hypertrophy. Circ Res. 58 1986:38-46.
CrossRef | PubMed
Ecker  T, Gobel  C, Hullin  R, Rettig  R, Seitz  G, Hofmann  F; Decreased cardiac concentration of cGMP kinase in hypertensive animals. An index for cardiac vascularization.  Circ Res. 65 1989:1361-1369.
Prisant  LM, von Dohlen  TW, Houghton  JL, Carr  AA, Frank  MJ; A negative thallium (± dipyridamole) stress test excludes significant obstructive epicardial coronary disease in hypertensive patients. Am J Hypertens. 5 1992:71-75.
PubMed
Depuey  EG, Guertler-Krawczynska  E, Perkins  JV, Robbins  WL, Whelchel  JD, Clements  SD; Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography. Am J Cardiol. 62 1988:234-238.
CrossRef | PubMed
Houghton  TL, Frank  MJ, Carr  AA, Vondohlen  TW, Prisant  LM; Relations among impaired coronary flow reserve, left ventricular hypertrophy, and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol. 15 1990:43-51.
CrossRef | PubMed
Marwick  T, Cook  SA, Lafont  A, Underwood  DA, Salcedo  EE; Influence of left ventricular mass on the diagnostic accuracy of myocardial perfusion imaging using positron emission tomography with dipyridamole stress. J Nucl Med. 32 1991:2221-2226.
PubMed
Marwick  T, D'Hondt  AM, Baudhuin  T; Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography, scintigraphy or both?. J Am Coll Cardiol. 22 1993:159-167.
CrossRef | PubMed
Tubau  JF, Szlachcic  J, Braun  S, Massie  BM; Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy. Hypertension. 14 1989:1-8.
CrossRef | PubMed
Romhilt  DW, Estes  EH; A point score system for the electrocardiogram diagnosis of left ventricular hypertrophy. Am Heart J. 75 1968:752-758.
CrossRef | PubMed
Ellestad  M; Stress Testing.3rd ed. 1986 FA Davis St. Louis (MO)
Sahn  DJ, De Maria  A, Kisslo  J, Weyman  A; Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 58 1978:1071-1083.
Devereux  RB, Reichek  N; Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 55 1977:613-618.
CrossRef | PubMed
Devereux  RB, Alonso  DR, Lutas  EM; Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 57 1986:450-458.
CrossRef | PubMed
Levy  D, Savage  DD, Garrison  RJ, Anderson  KM, Kannel  WB, Castelli  WP; Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 59 1987:956-960.
CrossRef | PubMed
Detrano  R, Froelicher  VF; Exercise testing: uses and limitations considering recent studies. Prog Cardiovasc Dis. 31 1988:173-204.
CrossRef | PubMed
Ryan  T, Vasey  CG, Presti  CF, O'Donnell  J, Feigenbaum  H, Armstrong  WF; Exercise echocardiography: detection of coronary artery disease in patients with normal left ventricular wall motion at rest. J Am Coll Cardiol. 11 1988:993-999.
CrossRef | PubMed
Pozzoli  MM, Fioretti  PM, Salustri  A, Reijs  AE, Roelandt  JR; Exercise echocardiography and technetium-99m MIBI single photon emission computed tomography in the detection of coronary artery disease. Am J Cardiol. 67 1991:350-355.
CrossRef | PubMed
Sheikh  KH, Bengtson  JR, Helmy  S; Relation of quantitative coronary lesion measurements to the development of exercise-induced ischemia assessed by exercise echocardiography. J Am Coll Cardiol. 15 1990:1043-1051.
CrossRef | PubMed
Marwick  T, Nemec  J, Pashkow  F, Stewart  WJ, Salcedo  E; Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol. 19 1992:74-81.
CrossRef | PubMed
Ryan  T, Segar  DS, Sawada  SG; Detection of coronary artery disease with upright bicycle exercise echocardiography. J Am Soc Echocardiogr. 6 1993:186-197.
PubMed
Crouse  LJ, Harbrecht  JJ, Vacek  JL, Rosamond  TL, Kramer  PH; Exercise echocardiography as a screening test for coronary artery disease and correlation with angiography. Am J Cardiol. 67 1991:1213-1218.
CrossRef | PubMed
Lattanzi  F, Picano  E, Bolognese  L; Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans: correlation with exercise echocardiography. Circulation. 83 1991:1256-1262.
CrossRef | PubMed
Ferrara  N, Longobardi  G, Nicolino  A; Effect of beta-adrenoceptor blockade on dipyridamole-induced myocardial asynergies in coronary artery disease. Am J Cardiol. 70 1992:724-727.
CrossRef | PubMed
Marcus  ML, Mueller  TM, Gascho  JA, Kerber  RE; Effects of cardiac hypertrophy secondary to hypertension on the coronary circulation. Am J Cardiol. 44 1979:1023-1028.
CrossRef | PubMed
Bache  RJ, Vrobel  TR, Arentzen  CE, Ring  WS; Effect of maximum coronary vasodilation on transmural myocardial perfusion during tachycardia in dogs with left ventricular hypertrophy. Circ Res. 49 1981:742-750.
CrossRef | PubMed

Figures

Tables

Interactive Graphics

Video

References

Harris  CN, Aronow  WS, Parker  DP, Kaplan  MA; Treadmill stress test in left ventricular hypertrophy. Chest. 63 1973:353-358.
CrossRef | PubMed
Ellestad  MH, Savitz  S, Bergdall  D, Teske  J; The false positive stress test multivariate analysis of 215 subjects with hemodynamic, angiographic and clinical data. Am J Cardiol. 40 1977:681-685.
CrossRef | PubMed
Prisant  LM, Frank  MJ, Carr  AA, von Dohlen  TW, Abdulla  AM; How can we diagnose coronary heart disease in hypertensive patients?. Hypertension. 10 1987:467-472.
CrossRef | PubMed
Tomanek  RJ, Palmer  PJ, Peiffer  GL, Schreiber  KL, Eastham  CL, Marcus  ML; Morphometry of canine coronary arteries, arterioles and capilleries during hypertension and left ventricular hypertrophy. Circ Res. 58 1986:38-46.
CrossRef | PubMed
Ecker  T, Gobel  C, Hullin  R, Rettig  R, Seitz  G, Hofmann  F; Decreased cardiac concentration of cGMP kinase in hypertensive animals. An index for cardiac vascularization.  Circ Res. 65 1989:1361-1369.
Prisant  LM, von Dohlen  TW, Houghton  JL, Carr  AA, Frank  MJ; A negative thallium (± dipyridamole) stress test excludes significant obstructive epicardial coronary disease in hypertensive patients. Am J Hypertens. 5 1992:71-75.
PubMed
Depuey  EG, Guertler-Krawczynska  E, Perkins  JV, Robbins  WL, Whelchel  JD, Clements  SD; Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography. Am J Cardiol. 62 1988:234-238.
CrossRef | PubMed
Houghton  TL, Frank  MJ, Carr  AA, Vondohlen  TW, Prisant  LM; Relations among impaired coronary flow reserve, left ventricular hypertrophy, and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol. 15 1990:43-51.
CrossRef | PubMed
Marwick  T, Cook  SA, Lafont  A, Underwood  DA, Salcedo  EE; Influence of left ventricular mass on the diagnostic accuracy of myocardial perfusion imaging using positron emission tomography with dipyridamole stress. J Nucl Med. 32 1991:2221-2226.
PubMed
Marwick  T, D'Hondt  AM, Baudhuin  T; Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography, scintigraphy or both?. J Am Coll Cardiol. 22 1993:159-167.
CrossRef | PubMed
Tubau  JF, Szlachcic  J, Braun  S, Massie  BM; Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy. Hypertension. 14 1989:1-8.
CrossRef | PubMed
Romhilt  DW, Estes  EH; A point score system for the electrocardiogram diagnosis of left ventricular hypertrophy. Am Heart J. 75 1968:752-758.
CrossRef | PubMed
Ellestad  M; Stress Testing.3rd ed. 1986 FA Davis St. Louis (MO)
Sahn  DJ, De Maria  A, Kisslo  J, Weyman  A; Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 58 1978:1071-1083.
Devereux  RB, Reichek  N; Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 55 1977:613-618.
CrossRef | PubMed
Devereux  RB, Alonso  DR, Lutas  EM; Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 57 1986:450-458.
CrossRef | PubMed
Levy  D, Savage  DD, Garrison  RJ, Anderson  KM, Kannel  WB, Castelli  WP; Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 59 1987:956-960.
CrossRef | PubMed
Detrano  R, Froelicher  VF; Exercise testing: uses and limitations considering recent studies. Prog Cardiovasc Dis. 31 1988:173-204.
CrossRef | PubMed
Ryan  T, Vasey  CG, Presti  CF, O'Donnell  J, Feigenbaum  H, Armstrong  WF; Exercise echocardiography: detection of coronary artery disease in patients with normal left ventricular wall motion at rest. J Am Coll Cardiol. 11 1988:993-999.
CrossRef | PubMed
Pozzoli  MM, Fioretti  PM, Salustri  A, Reijs  AE, Roelandt  JR; Exercise echocardiography and technetium-99m MIBI single photon emission computed tomography in the detection of coronary artery disease. Am J Cardiol. 67 1991:350-355.
CrossRef | PubMed
Sheikh  KH, Bengtson  JR, Helmy  S; Relation of quantitative coronary lesion measurements to the development of exercise-induced ischemia assessed by exercise echocardiography. J Am Coll Cardiol. 15 1990:1043-1051.
CrossRef | PubMed
Marwick  T, Nemec  J, Pashkow  F, Stewart  WJ, Salcedo  E; Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol. 19 1992:74-81.
CrossRef | PubMed
Ryan  T, Segar  DS, Sawada  SG; Detection of coronary artery disease with upright bicycle exercise echocardiography. J Am Soc Echocardiogr. 6 1993:186-197.
PubMed
Crouse  LJ, Harbrecht  JJ, Vacek  JL, Rosamond  TL, Kramer  PH; Exercise echocardiography as a screening test for coronary artery disease and correlation with angiography. Am J Cardiol. 67 1991:1213-1218.
CrossRef | PubMed
Lattanzi  F, Picano  E, Bolognese  L; Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans: correlation with exercise echocardiography. Circulation. 83 1991:1256-1262.
CrossRef | PubMed
Ferrara  N, Longobardi  G, Nicolino  A; Effect of beta-adrenoceptor blockade on dipyridamole-induced myocardial asynergies in coronary artery disease. Am J Cardiol. 70 1992:724-727.
CrossRef | PubMed
Marcus  ML, Mueller  TM, Gascho  JA, Kerber  RE; Effects of cardiac hypertrophy secondary to hypertension on the coronary circulation. Am J Cardiol. 44 1979:1023-1028.
CrossRef | PubMed
Bache  RJ, Vrobel  TR, Arentzen  CE, Ring  WS; Effect of maximum coronary vasodilation on transmural myocardial perfusion during tachycardia in dogs with left ventricular hypertrophy. Circ Res. 49 1981:742-750.
CrossRef | PubMed

Correspondence

Latest JACC CME

Continuing Medical Education through JACC is a convenient way to fulfill your CME requirements while learning important information about the latest advances in cardiovascular medicine.

April 2013- JACC CME Activity
Repeat Revascularization and Outcome

March 2013- JACC CME Activity
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

Feb 2013- JACC CME Activity
Results from the BARI 2D Trial

Jan 2013- JACC CME Activity
Prognosis Among Healthy Individuals Discharged With a Primary Diagnosis of Syncope

Dec 2012- JACC CME Activity
Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

Nov 2012- JACC CME Activity
A Collaborative Analysis of Individual Patient Data From 10 Randomized Trials

Oct 2012- JACC CME Activity
Radiofrequency Ablation of Premature Ventricular Ectopy Improves the Efficacy of Cardiac Resynchronization Therapy in Nonresponders

Sept 2012- JACC CME Activity
Exercise and Pharmacological Treatment of Depressive Symptoms in Patients With Coronary Heart Disease

Aug 2012- JACC CME Activity
Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

July 2012- JACC CME Activity
Relationship of Beta-Blocker Dose With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction

For previous CME quizzes, please follow this link to CardioSource Lifelong Learning and MOC.

 

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles